Diagenics has patented antibodies to this enzyme and has already developed a new line of products for the early diagnosis of stroke: DIASTROKE®. The product was CE registered based on a study. Future studies will expand our expertise in stroke diagnosis.
DIAGENICS has patented antibodies to this enzyme and has already developed a new product line for the early diagnosis of chest pain patients for the detection of heart attacks: DIACORDON®. Current and future studies will also expand our knowledge in the field of heart attack diagnosis and the success of the course of treatment (monitoring).